RT Journal Article SR Electronic T1 Enteral yeast–selenium supplementation in preterm infants JF Archives of Disease in Childhood - Fetal and Neonatal Edition JO Arch Dis Child Fetal Neonatal Ed FD BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health SP F225 OP F226 DO 10.1136/fn.78.3.F225 VO 78 IS 3 A1 Gábor Bogye A1 Georg Alfthan A1 Tamás Machay A1 László Zubovics YR 1998 UL http://fn.bmj.com/content/78/3/F225.abstract AB AIM To study the bioavailability of selenium enriched yeast in preterm infants living in a low selenium area (Hungary). METHODS Thirty six preterm infants were randomly assigned to two groups at birth with respect to selenium supplementation. In the supplemented group (n=18) infants received 4.8 mg of selenium enriched yeast containing 5 μg selenium daily. RESULTS In the supplemented group the serum selenium concentration increased from 36.1(±12.8) μg/l to 43.5 (7.9) μg/l and in the non-supplemented group it decreased from 34.4 (20.4) μg/l to 26.1 (16.6) μg/l from birth in two weeks. No complications or side effects as a result of supplementation were observed. CONCLUSIONS Selenium enriched yeast is a safe and an effective form of short term enteral selenium supplementation for preterm infants.